eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Comorbidity | C0024299|lymphoma |
| Sentences | 3 |
| PubMedID- 25170012 | Fda approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. |
| PubMedID- 24723496 | Cytomorphology of non-small cell lung carcinoma with anaplastic lymphoma kinase gene rearrangement. |
| PubMedID- 22465695 | Fluorescence in situ hybridization (fish) is currently used to detect non-small cell lung cancer (nsclc) patients with anaplastic lymphoma kinase (alk) gene rearrangement, who are candidates for alk inhibitor therapy. |
Page: 1